speculative risky BuyBuy now with a first target at 3 then 7
but if we close daily below 2.45 then its invalid
stop loss at 2 tp : 3 then 7
0.17EUR
1.57 MEUR
20.05 MEUR
2.16 M
About GENOWAY
Sector
Industry
CEO
Christian Grenier
Website
Headquarters
Lyon
Founded
1999
ISIN
FR0004053510
FIGI
BBG000R890N7
genOway SA engages in the development of genetically-modified mouse, rat, and cellular models for biopharmaceutical and research companies. Its technologies include CRISPR/Cas9, homologous recombination (HR), site-specific recombination (SSR), internal ribosome entry sites (IRES), and tetracycline (TET). The company was founded by Alexandre Fraichard and Gilles de Poncins on March 1, 1999 and is headquartered in Lyon, France.
Corona Stock : Ready for 60% !genOway is a biotechnology company specializing in the design and development of molecular, cellular and animal research models with high added value for the biopharmaceutical, chemical, agrochemical and agrifood industries as well as for academic research. genOway is a leading company in its market
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ALGEN is 3.93 EUR — it has decreased by 0.51% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange GENOWAY stocks are traded under the ticker ALGEN.
ALGEN stock is 2.04% volatile and has beta coefficient of 0.41. Check out the list of the most volatile stocks — is GENOWAY there?
One year price forecast for GENOWAY has a max estimate of 6.60 EUR and a min estimate of 6.60 EUR.
Yes, you can track GENOWAY financials in yearly and quarterly reports right on TradingView.
ALGEN stock has fallen by 5.07% compared to the previous week, the month change is a 4.15% fall, over the last year GENOWAY has showed a 2.61% increase.
ALGEN net income for the last quarter is 550.11 K EUR, while the quarter before that showed 1.02 M EUR of net income which accounts for −45.96% change. Track more GENOWAY financial stats to get the full picture.
Today GENOWAY has the market capitalization of 35.66 M, it has decreased by 0.48% over the last week.
No, ALGEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOWAY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOWAY technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOWAY stock shows the neutral signal. See more of GENOWAY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GENOWAY future price: according to them, ALGEN price has a max estimate of 6.60 EUR and a min estimate of 6.60 EUR. Read a more detailed GENOWAY forecast: see what analysts think of GENOWAY and suggest that you do with its stocks.